Position
Fidelity in Cullinan Therapeutics, Inc.
Back to the book · All holders of CGEM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $28.9K$14.21 → $18.21
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 4.6K | $47.6K | — | — | — | 0.0% |
| Q1 2026 | 7.23K | $102.8K | $14.21 | $17.8K | $37.4K | 0.0% |
| Q2 2026 | 240.1K | $4.37M | $18.21 | $28.9K | $4.24M | 0.0% |